Clinical Trial Update: Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated pleiotropic effects of atorvastatin in high cardiovascular risk patients and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Hippocration General Hospital | Conditions: Coronary Artery Disease, HMG-CoA Reductase Inhibitor Toxicity | Phase 4 | Status: COMPLETED